5COPPLESTONE J A, SMITH A G. Acute myeloid leukemia in the elderly[J].Leuke Res, 1998, 12:617-625.
6YAMADA K, FURUSAWA S, SAITO K, et al.Concurrent use of granulocyte colony-stimulating factor with low-dose cytosine arabinoside and aclarubicin for previously treated acute myelogenous leukemia: a pilot study[J].Leukemia, 1995, 9 : 10-14.
7SAITO K, NAKAMURA Y, AOYAGI M, et al.Low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor (CAG regimen) for previously treated patients with relapsed or primary resistant acute myelogenous leukemia (AML)and previously untreated elderly patients with AML,secondary AML, and refractory anemia with excess blasts in transformation[J].Int J Hematol, 2000,71:238-244.
8HIRAYAMA Y, SAKAMAKI S, TAKAYANAGI N, et al. Chemotherapy with ubenimex corresponding to patient age and organ disorder for 18 cases of acute myelogeneous leukemia in elderly patients-effects,complications and long-term survival[J].Gan To Kagaku Ryoho, 2003, 30:1113-1118.
9LOWENBERG B, PUTTEN W, THEOBALD M, et al. Effect of priming with granulocyte colony-stimulating factor on the outcome of chemotherapy for acute myeloid leukemia[J].N Engl J Med, 2003, 349:743-752.
10TABATA M,YOSHIDA M,IZUMI T,et al.Retrospective analysis of elderly patients＞or=60 years of age with acute leukemia[J].Rinsho Ketsueki,1998,39:176-184
1Yamada K,Furusawa S,Saito K,et al. Concurrent use of granulocyte colony-stimulating factor with low-dose cytosine arabinoside and aclarubicin for previously treated acute myelogenous leukemia:a pilot study[J]. Leukemia, 1995,9 (1):10-14.
2Estey E. AML in older patients:are we making progress[J]. Best Pract Res Clin Haematol, 2009,22(4) : 529-536.
3Wei G,Ni W,Chiao JW,et al. A meta-analysis of CAG (cy- tarabine,aclarubicin,G-CSF) regimen for the treatment of 1029 patients with acute myeloid leukemia and myelodys- plastic syndrome[J]. J Hematol Oncol, 2011,14(4) :46.
4Bai A, Kojima H, Hori M,et al. Priming with G-CSF effective- ly enhances low-dose Ara-C-induced in vivo apoptosis in myeloid leukemia cell[J]. Exp Hematol, 1999,27(2): 259-265.
5Reuter C,Schleyer E, Rolf C,et al. Differential effect of GM-CSF pretreatment on intracellular Ara-C metabolism in normal bone marrow mononuclear cells vs acute myeloid leukemia (AML) blasts[J]. Leukemia, 1997,11 (4): 561-571.
6Akashi K,Eto T,Shibuya T,et al. Aclarubicin induces differentiation of leukemic progenitors in myelodysplastic syndrome cooperating with granulocyte colony-stimulating factor[J]. Leuk Res, 2000,24(3) : 243-248.
